showed a trendp = 0.081
For DLCO% decline, no significant differences were observed ( p = 0.43); however, nfHP patients showed a trend towards an immediate DLCO% increase of 3.38% after corticoid treatment initiation ( p = 0.081).
For DLCO% decline, no significant differences were observed ( p = 0.43); however, nfHP patients showed a trend towards an immediate DLCO% increase of 3.38% after corticoid treatment initiation ( p = 0.081).
While exposure avoidance was significant with both FVC% and DLCO% decline reversed in nfHP and a positive trend in the FVC% decline in the fHP subgroup, no clear impact of exposure avoidance on survival was seen.